Holen Sie sich die Stockscreener-App
28.23
6.86%
-2.08
Handel nachbörslich:
28.64
0.41
+1.45%
Schlusskurs vom Vortag:
$30.31
Offen:
$26.66
24-Stunden-Volumen:
87,818
Relative Volume:
1.73
Marktkapitalisierung:
$1.35B
Einnahmen:
$27,600
Nettoeinkommen (Verlust:
$-36.04M
KGV:
-35.43
EPS:
-0.7968
Netto-Cashflow:
$-1.66M
1W Leistung:
+34.62%
1M Leistung:
+191.07%
6M Leistung:
+747.75%
1J Leistung:
+474.95%
1-Tages-Spanne:
$26.61
$29.34
1-Wochen-Bereich:
$23.31
$30.35
52-Wochen-Spanne:
$2.76
$30.35
Nanobiotix Adr Stock (NBTX) Company Profile
Vergleichen Sie NBTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
28.23 | 1.14B | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
Orion, Nio, Alibaba Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Pre Market Movers: NBTX, IMTX, QNRX See Big Swings - RTTNews
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Nanobiotix (NASDAQ:NBTX) Shares Down 12%Should You Sell? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpHere's Why - MarketBeat
Morning Market Movers: XBIO, UPC, GLTO Spark Big Moves - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's Why - MarketBeat
FY2027 EPS Estimates for Nanobiotix Boosted by HC Wainwright - Defense World
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances - TipRanks
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - Benzinga
Morning Market Movers: SPRC, VALN, NBY, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Reaches New 1-Year HighHere's Why - MarketBeat
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC - GlobeNewswire Inc.
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Hits New 52-Week HighHere's Why - MarketBeat
Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Short Interest Up 23.7% in August - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 11.8% HigherTime to Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Up 5.7%What's Next? - MarketBeat
Nanobiotix announces new results from JNJ-1900 study - TipRanks
Nanobiotix Announces Voting Rights and Share Capital Update - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.2% – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 2.9% – Should You Buy? - Defense World
Guggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX) - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% – Should You Sell? - Defense World
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Guggenheim cuts Nanobiotix stock target to $8, maintains buy - Investing.com
Nanobiotix SA ADR Reports 2024 Financial Results - TipRanks
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study - Nasdaq
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study - TipRanks
Nanobiotix (NBTX) Stock Soared 107.9% on a Global Pharma Deal - AskTraders.com
Stock Market News and Commentary - Barchart.com
Nanobiotix S.A.Sponsored ADR (NBTX) - Zacks Investment Research
NBTX News Today | Why did Nanobiotix stock go up today? - MarketBeat
Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):